These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3276190)

  • 21. [Sternoclavicular arthritis caused by Streptococcus pyogenes group A complicated by mediastinal abscess in a patient infected with the HIV virus].
    Chamot AM; Gerster JC
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):663-4. PubMed ID: 2075405
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological assessments of streptococcal infection by comparison of antibody titres to streptococcal extracellular antigens.
    el-Khateeb MS
    J Trop Pediatr; 1988 Oct; 34(5):251-3. PubMed ID: 3058993
    [No Abstract]   [Full Text] [Related]  

  • 23. Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease.
    Akesson P; Rasmussen M; Mascini E; von Pawel-Rammingen U; Janulczyk R; Collin M; Olsen A; Mattsson E; Olsson ML; Bjorck L; Christensson B
    J Infect Dis; 2004 Mar; 189(5):797-804. PubMed ID: 14976595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes.
    Yuste J; Ali S; Sriskandan S; Hyams C; Botto M; Brown JS
    J Immunol; 2006 May; 176(10):6112-20. PubMed ID: 16670320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of Streptococcus pyogenes (group A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use.
    Navarro VJ; Axelrod PI; Pinover W; Hockfield HS; Kostman JR
    Arch Intern Med; 1993 Dec; 153(23):2679-84. PubMed ID: 8250663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary specific antibodies in relation to adhesion of Streptococcus pyogenes to pharyngeal cells of patients with rheumatic fever and rheumatic heart disease.
    Kumar KS; Ganguly NK; Chandrashekher Y; Anand IS; Wahi PL
    Adv Exp Med Biol; 1995; 371A():677-9. PubMed ID: 8526017
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas aeruginosa sepsis and ecthyma gangrenosum as initial manifestations of primary immunodeficiency.
    Baro M; Marín MA; Ruiz-Contreras J; de Miguel SF; Sánchez-Díaz I
    Eur J Pediatr; 2004 Mar; 163(3):173-4. PubMed ID: 14689307
    [No Abstract]   [Full Text] [Related]  

  • 28. [Severe group A streptococci infections. Decreased immunity is a possible cause].
    Holm SE
    Lakartidningen; 1989 Feb; 86(6):413-5. PubMed ID: 2645486
    [No Abstract]   [Full Text] [Related]  

  • 29. IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.
    Akesson P; Moritz L; Truedsson M; Christensson B; von Pawel-Rammingen U
    Infect Immun; 2006 Jan; 74(1):497-503. PubMed ID: 16369006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of immune parameters in a patient with sepsis caused by Streptococcus pyogenes treated with activated protein C.
    Holub M; Helcl M; Beran O; Hnyková J; Príhodová J
    Scand J Infect Dis; 2004; 36(6-7):485-8. PubMed ID: 15307574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis.
    Vasey FB; Deitz C; Fenske NA; Germain BF; Espinoza LR
    J Rheumatol; 1982; 9(5):719-22. PubMed ID: 6757423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection.
    Deicke C; Chakrakodi B; Pils MC; Dickneite G; Johansson L; Medina E; Loof TG
    Int J Med Microbiol; 2016 Nov; 306(7):572-579. PubMed ID: 27338836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein SIC Secreted from
    Westman J; Chakrakodi B; Snäll J; Mörgelin M; Bruun Madsen M; Hyldegaard O; Neumann A; Frick IM; Norrby-Teglund A; Björck L; Herwald H
    Front Immunol; 2018; 9():236. PubMed ID: 29520265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
    Olive C; Schulze K; Sun HK; Ebensen T; Horváth A; Toth I; Guzman CA
    Vaccine; 2007 Feb; 25(10):1789-97. PubMed ID: 17229503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human antibodies to group A streptococcal carbohydrate. Ontogeny, subclass restriction, and clonal diversity.
    Shackelford PG; Nelson SJ; Palma AT; Nahm MH
    J Immunol; 1988 May; 140(9):3200-5. PubMed ID: 3283244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probable role of Streptococcus pyogenes in Kawasaki disease.
    Akiyama T; Yashiro K
    Eur J Pediatr; 1993 Feb; 152(2):82-92. PubMed ID: 8444235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection and T lymphocyte subpopulations: changes associated with bacteremia and the acquired immunodeficiency syndrome.
    Fishman JA; Martell KM; Rubin RH
    Diagn Immunol; 1983; 1(3):261-5. PubMed ID: 6094086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe streptococcal axillary lymphadenitis.
    Boyce JM
    N Engl J Med; 1990 Sep; 323(10):655-8. PubMed ID: 2200967
    [No Abstract]   [Full Text] [Related]  

  • 39. Group A streptococcal infections of the skin and pharynx (first of two parts).
    Peter G; Smith AL
    N Engl J Med; 1977 Aug; 297(6):311-7. PubMed ID: 327323
    [No Abstract]   [Full Text] [Related]  

  • 40. SIgA- and IgG-coated Streptococcus pyogenes on the tonsillar surfaces during acute tonsillitis.
    Lilja M; Silvola J; Bye HM; Räisänen S; Stenfors LE
    Acta Otolaryngol; 1999; 119(6):718-23. PubMed ID: 10587008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.